Kelly Leanne 4
4 · GRI Bio, Inc. · Filed Aug 27, 2025
Insider Transaction Report
Form 4
Kelly Leanne
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2025-08-26+11,854→ 11,854 totalExercise: $1.41Exp: 2035-08-26→ Common Stock (11,854 underlying)
Footnotes (1)
- [F1]Options to purchase 7,424 shares vested in full upon the date of grant and options to purchase 4,430 shares will vest in 12 substantially equal quarterly installments such that the stock option is fully vested on the third anniversary of the date of grant.